Search Within

Gary Schwartz

  1. "2012"
Formats
  1. Meeting Abstract (18)
  2. Journal Article (13)
Groups
  1. Department of Medicine (21)
  2. Solid Tumor Oncology Division (20)
  3. Sarcoma Service (13)
  4. GSK Faculty (12)
  5. Biostatistics Service (8)
  6. Department of Pathology and Laboratory Medicine (8)

More Groups

People
  1. Richard Carvajal (11)
  2. Mark Dickson (9)
  3. William Tap (7)
  4. Sandra D'Angelo (6)
  5. Cristina Antonescu (5)
  6. Li-Xuan Qin (5)

More People

Years
  1. 2012 (31)
Publications
  1. Journal of Clinical Oncology (13)
  2. Clinical Cancer Research (3)
  3. Annals of Oncology (2)
  4. Cancer Research (2)
  5. Autophagy (1)
  6. British Journal of Cancer (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. American Association for Cancer Research (6)
  3. Nature Publishing Group (2)
  4. Oxford University Press (2)
  5. Elsevier Inc. (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase Ib/II study evaluating the efficacy of doxorubicin (D) with or without a human anti-PDGFR alpha monoclonal antibody olaratumab (IMC-3G3) in the treatment of advanced soft tissue sarcoma (STS)
    Meeting Abstract

    Tap, W. D.; Van Tine, B. A.; Elias, A. D.; Livingston, M. B.; Agulnik, M.; Cooney, M. M.; Chmielowski, B.; Brenner, A. J.; Pennock, G. K.; Somaiah, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase II multicenter study of the IGF-1 receptor antibody cixutumumab (A12) and the mTOR inhibitor temsirolimus (TEM) in patients (pts) with refractory IGF-1R positive (+) and negative (-) bone and soft tissue sarcomas (STS)
    Meeting Abstract

    Schwartz, G. K.; Tap, W. D.; Qin, L. X.; Livingston, M. B.; Undevia, S. D.; Chmielowski, B.; Agulnik, M.; Schuetze, S.; Reed, D. R.; Okuno, S. H.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg)
    Meeting Abstract

    Postow, M. A.; Yuan, J.; Panageas, K.; Bogatch, K.; Callahan, M.; Cheng, M.; Schroeder, S. E. A.; Kendle, R. F.; Harding, J. J.; Dickson, M. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase I study of MDM2 antagonist RG7112 in patients (pts) with relapsed/refractory solid tumors
    Meeting Abstract

    Kurzrock, R.; Blay, J. Y.; Nguyen, B. B.; Wagner, A. J.; Maki, R. G.; Schwartz, G. K.; Patnaik, A.; Gore, L.; Wu, L.; Vassilev, L. T.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A multicenter random assignment phase II study of irinotecan and flavopiridol versus irinotecan alone for patients with p53 wild-type gastric adenocarcinoma (NCI 8060)
    Meeting Abstract

    Janjigian, Y. Y.; Tang, L. H.; Shibata, S.; Kelsen, D. P.; Segal, M.; Cheng, C.; Schwartz, G. K.; Doyle, L. A.; Shah, M. A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A first-in-human, phase Ib combination study to assess safety, pharmacokinetics (PK), and pharmacodynamics (PD) of a hedgehog inhibitor, GDC-0449, with a Notch inhibitor, RO4929097, in patients with advanced sarcoma
    Meeting Abstract

    Gounder, M. M.; Dickson, M. A.; Wu, N.; Ivy, S. P.; Carvajal, R. D.; D'Angelo, S. P.; Keohan, M. L.; Qin, L. X.; Erinjeri, J. P.; Takebe, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Circulating VEGF levels as a biomarker to clinical benefit to PTC299, the first inhibitor of VEGF synthesis
    Meeting Abstract

    George, C. P.; Luke, J. J.; Winkelman, J.; Cao, Y. T. K. H.; Shakes, L.; Donnelly, K.; Darby, C. H.; Davis, T. W.; Elfring, G. L.; Schwartz, G. K.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II trial of the CDK4 inhibitor PD0332991 in CDK4-amplified liposarcoma
    Meeting Abstract

    Dickson, M. A.; Keohan, M. L.; Tap, W. D.; Antonescu, C.; Landa, J.; Qin, L. X.; Dohrenwend, E. G.; Rathbone, D.; Ustoyev, Y.; Condy, M. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Activity of sorafenib in radiation-associated breast angiosarcomas harboring MYC and FLT4 amplifications
    Meeting Abstract

    D'Angelo, S. P.; Antonescu, C. R.; Keohan, M. L.; Carvajal, R. D.; Dickson, M. A.; Gounder, M. M.; Moraco, N. H.; Singer, S.; Schwartz, G. K.; Tap, W. D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Pharmacodynamic activity of selumetinib to predict radiographic response in advanced uveal melanoma
    Meeting Abstract

    Carvajal, R. D.; Ambrosini, G.; Wolchok, J. D.; Chapman, P. B.; Dickson, M. A.; D'Angelo, S. P.; Bluth, M. J.; Paucar, D.; Fusco, A.; Bohr, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save